Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Reads Medical Products, Inc.

US

Last updated May 23, 2026

What Reads Medical Products, Inc. makes

Reads Medical Products, Inc. manufactures in vitro diagnostic test kits for detecting specific autoantibodies, including the READS(R) IgA anti-cardiolipin test kit and the antinuclear antibody (ANA) screening test kit. These products are designed for laboratory use to identify markers associated with autoimmune conditions.

The company’s portfolio consists of Class II in vitro diagnostic devices, regulated under the FDA’s 510(k) clearance process. These products are listed in the FDA’s 510(k) database, reflecting their compliance with U.S. regulatory requirements. The manufacturer is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Reads Medical Products, Inc. manufacture?

Reads Medical Products, Inc. specializes in in vitro diagnostic (IVD) test kits. Specifically, their products detect autoantibodies, such as the READS(R) IgA anti-cardiolipin test kit and the antinuclear antibody (ANA) screening test kit. These tests are designed for laboratory use to help identify biomarkers linked to autoimmune diseases.

Where is Reads Medical Products, Inc. based, and how does that affect its regulatory standing?

Reads Medical Products, Inc. is based in the United States. Since the company’s devices are regulated under U.S. jurisdiction, they must comply with FDA requirements. Their products fall under the FDA’s 510(k) clearance process, which is a premarket submission to demonstrate substantial equivalence to a legally marketed predicate device.

Which regulatory registries list Reads Medical Products, Inc.’s devices, and why?

Reads Medical Products, Inc.’s devices are listed in the FDA’s 510(k) database. This registry reflects compliance with U.S. regulatory requirements for Class II in vitro diagnostic devices, ensuring their safety and performance meet FDA standards before market authorization.

How are Reads Medical Products, Inc.’s devices classified, and what does that classification mean?

Reads Medical Products, Inc.’s devices are classified as Class II in vitro diagnostics. This classification indicates moderate regulatory control, requiring manufacturers to demonstrate that their products are substantially equivalent to a legally marketed predicate device through the FDA’s 510(k) process, ensuring they meet specific performance and safety standards.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (15)

DeviceModel / ReferenceRegistriesClassStatus
Revo Medical RM1792
FDA UDI
Class IIActive
Revo Medical RM1797
FDA UDI
Class IIActive
Revo Medical RM1791
FDA UDI
Class IIActive
Revo Medical RM1798
FDA UDI
Class IIActive
Revo Medical RM1788
FDA UDI
Class IIActive
Revo Medical RM1789
FDA UDI
Class IIActive
Revo Medical RM1790
FDA UDI
Class IIActive
Revo Medical RM1794
FDA UDI
Class IIActive
Revo Medical RM1793
FDA UDI
Class IIActive
Reads(r) Iga Anti-Cardiolipin Test Kit K914405
FDA 510(k)
Class IIActive
Reaads Von Willebrand Factor Antigen Test Kit K972005
FDA 510(k)
Class IIActive
Reaads Anti-Phosphatidylserine Quantitative Test Kit K952287
FDA 510(k)
Class IIActive
Reaads Protein C Antigen Test Kit K972342
FDA 510(k)
Class IIActive
Reaads Protein S Antigen Test Kit K972482
FDA 510(k)
Class IIActive
Antinuclear Antibody (ana) Screening Test Kit K914853
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.